PROVIDER SERVICE NETWORKS FOR PHARMACIST CONTRACTING SHOULD BE ALLOWED BY FTC, APhA PRESIDENT ARGUES; KNOWLTON AND HOSCHEIT ADDRESS DECLINING MARGINS
Executive Summary
Pharmacists should be able to join together to refuse third-party reimbursement schemes that they view as inadequate, American Pharmaceutical Association President Calvin Knowlton, PhD, argued in comments to the Federal Trade Commission at a Nov. 8 hearing on the effect of "the changing nature of competition in a global and innovation-driven age" on small business.
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth